533 results on '"Litzow, Mark R"'
Search Results
2. Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
3. A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission
4. Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
5. Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia
6. Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators
7. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide
8. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage
9. The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
10. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
11. Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
12. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
13. Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib
14. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia
15. CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
16. Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide Survey
17. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
18. Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation
19. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
20. Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
21. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia
22. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
23. TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
24. A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients
25. Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
26. Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
27. Survival following allogeneic transplant in patients with myelofibrosis
28. A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
29. T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia
30. Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia
31. Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia
32. Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
33. Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias
34. Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
35. Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection
36. Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
37. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
38. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
39. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study
40. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells
41. Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival
42. Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation
43. No free rides: management of toxicities of novel immunotherapies in ALL, including financial
44. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
45. Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
46. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
47. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
48. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series
49. Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
50. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.